The signing ceremony of boshengkang and Zhenxing medicine was held ceremoniously
2020-06-26
The signing ceremony between boshengkang and Zhenxing medicine was solemnly held. Boshengkang CEO Dr. Yang Yinke and his party's experts, Dr. Cheng Jianwu, chairman of Zhenxing medicine, and their team members attended the signing ceremony.
In this sunny and sunny day, the signing ceremony of the letter of intent for strategic cooperation between boshengkang and Zhenxing pharmaceutical was solemnly held in the conference room of Zhenxing pharmaceutical company
Dr. Yang Yinke, chief executive officer of boshengkang, Dr. Cheng Jianwu, chairman of Zhenxing pharmaceutical and his team members attended the signing ceremony.
In 2020, the novel coronavirus pneumonia outbreak suddenly came into being. The bio pharmaceutical industry has undoubtedly become a global hotspot, and promoted the strategic value of the biopharmaceutical industry. The biopharmaceutical industry is developing rapidly in China, and the pharmaceutical industry of the Zhenxing and Bo Sheng Kang is just in this industry. Dr. Yang Yinke, CEO of Bosheng Kang, said: we are both divided into labor and united to achieve win-win cooperation. The two companies can work together and make people confident. At present, both sides have a condition for rapid progress. Then I believe that our cooperation must be 1 plus 1 and more than 2. If we can unite, I believe that through cooperation, we will surely usher in a big development opportunity.
At the meeting, Mr. Cheng Jianwu, President of Zhenxing pharmaceutical, made a concluding speech: boshengkang, as a high-tech company with scientific and technological research and development strength composed of overseas study experts and doctors, has developed a number of competitive products over the years, which is very admirable. Similarly, Zhenxing pharmaceutical has been quietly working in the field of tumor innovative drugs for more than ten years. At present, a new class 1.1 drug has entered phase I clinical trials; a new class 1 drug has completed the approval procedures to the State Food and drug administration, and the other four new drugs are also in different research and development stages in the laboratory. The company has successfully completed round a financing and has a good development momentum at present. We sincerely hope that boshengkang and Zhenxing medicine can strengthen exchanges, speed up the discussion of future cooperation mode and create conditions for substantive cooperation on the basis of complementary advantages and win-win cooperation.
Finally, based on the principles of equality, mutual benefit and trustworthiness, adhering to the purpose of resource sharing, collaborative development and strong cooperation, the two companies agreed to carry out strategic cooperation with the goal of win-win cooperation. The team members of both sides witnessed the signing of the letter of intent for strategic cooperation between Zhenxing pharmaceutical and boshengkang. The signing ceremony ended successfully!
